211 related articles for article (PubMed ID: 36476474)
21. Polycomb-like 2 regulates PRC2 components to affect proliferation in glioma cells.
Wang F; Gao Y; Lv Y; Wu Y; Guo Y; Du F; Wang S; Yu J; Cao X; Li PA
J Neurooncol; 2020 Jun; 148(2):259-271. PubMed ID: 32436117
[TBL] [Abstract][Full Text] [Related]
22. IMITATION SWITCH is required for normal chromatin structure and gene repression in PRC2 target domains.
Kamei M; Ameri AJ; Ferraro AR; Bar-Peled Y; Zhao F; Ethridge CL; Lail K; Amirebrahimi M; Lipzen A; Ng V; Grigoriev IV; Schmitz RJ; Liu Y; Lewis ZA
Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33468665
[TBL] [Abstract][Full Text] [Related]
23. EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer.
Chinaranagari S; Sharma P; Chaudhary J
Oncotarget; 2014 Aug; 5(16):7172-82. PubMed ID: 25115397
[TBL] [Abstract][Full Text] [Related]
24. Not just a writer: PRC2 as a chromatin reader.
Uckelmann M; Davidovich C
Biochem Soc Trans; 2021 Jun; 49(3):1159-1170. PubMed ID: 34060617
[TBL] [Abstract][Full Text] [Related]
25. Kicking against the PRCs - A Domesticated Transposase Antagonises Silencing Mediated by Polycomb Group Proteins and Is an Accessory Component of Polycomb Repressive Complex 2.
Liang SC; Hartwig B; Perera P; Mora-García S; de Leau E; Thornton H; de Lima Alves F; Rappsilber J; Yang S; James GV; Schneeberger K; Finnegan EJ; Turck F; Goodrich J
PLoS Genet; 2015 Dec; 11(12):e1005660. PubMed ID: 26642436
[TBL] [Abstract][Full Text] [Related]
26. A new kinetochore component CENP-W interacts with the polycomb-group protein EZH2 to promote gene silencing.
Koh W; Park B; Lee S
Biochem Biophys Res Commun; 2015 Aug; 464(1):256-62. PubMed ID: 26111449
[TBL] [Abstract][Full Text] [Related]
27. Small Molecule Approaches for Targeting the Polycomb Repressive Complex 2 (PRC2) in Cancer.
Martin MC; Zeng G; Yu J; Schiltz GE
J Med Chem; 2020 Dec; 63(24):15344-15370. PubMed ID: 33283516
[TBL] [Abstract][Full Text] [Related]
28. EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation.
Mu W; Starmer J; Yee D; Magnuson T
Epigenetics Chromatin; 2018 Dec; 11(1):71. PubMed ID: 30522506
[TBL] [Abstract][Full Text] [Related]
29. Cooperation between the H3K27me3 Chromatin Mark and Non-CG Methylation in Epigenetic Regulation.
Zhou S; Liu X; Zhou C; Zhou Q; Zhao Y; Li G; Zhou DX
Plant Physiol; 2016 Oct; 172(2):1131-1141. PubMed ID: 27535791
[TBL] [Abstract][Full Text] [Related]
30. C10ORF12 modulates PRC2 histone methyltransferase activity and H3K27me3 levels.
Shi Y; Ma HL; Zhuang YW; Wang XX; Jiang Y; Xu HE
Acta Pharmacol Sin; 2019 Nov; 40(11):1457-1465. PubMed ID: 31186533
[TBL] [Abstract][Full Text] [Related]
31. Mutations and deletions of PRC2 in prostate cancer.
Jain P; Di Croce L
Bioessays; 2016 May; 38(5):446-54. PubMed ID: 27000413
[TBL] [Abstract][Full Text] [Related]
32. Proteomic Analyses Identify a Novel Role for EZH2 in the Initiation of Cancer Cell Drug Tolerance.
Pham V; Pitti R; Tindell CA; Cheung TK; Masselot A; Stephan JP; Guler GD; Wilson C; Lill J; Arnott D; Classon M
J Proteome Res; 2020 Apr; 19(4):1533-1547. PubMed ID: 32159963
[TBL] [Abstract][Full Text] [Related]
33. Polycomb recruitment at the Class II transactivator gene.
Boyd NH; Morgan JE; Greer SF
Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
[TBL] [Abstract][Full Text] [Related]
34. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.
Kirmizis A; Bartley SM; Kuzmichev A; Margueron R; Reinberg D; Green R; Farnham PJ
Genes Dev; 2004 Jul; 18(13):1592-605. PubMed ID: 15231737
[TBL] [Abstract][Full Text] [Related]
35. Molecular analysis of PRC2 recruitment to DNA in chromatin and its inhibition by RNA.
Wang X; Paucek RD; Gooding AR; Brown ZZ; Ge EJ; Muir TW; Cech TR
Nat Struct Mol Biol; 2017 Dec; 24(12):1028-1038. PubMed ID: 29058709
[TBL] [Abstract][Full Text] [Related]
36. Polycomb Repressive Complex 2 Methylates Elongin A to Regulate Transcription.
Ardehali MB; Anselmo A; Cochrane JC; Kundu S; Sadreyev RI; Kingston RE
Mol Cell; 2017 Dec; 68(5):872-884.e6. PubMed ID: 29153392
[TBL] [Abstract][Full Text] [Related]
37. MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines.
Terashima M; Tange S; Ishimura A; Suzuki T
J Biol Chem; 2017 Jan; 292(1):82-99. PubMed ID: 27852821
[TBL] [Abstract][Full Text] [Related]
38. PRC2-independent chromatin compaction and transcriptional repression in cancer.
Vallot C; Hérault A; Boyle S; Bickmore WA; Radvanyi F
Oncogene; 2015 Feb; 34(6):741-51. PubMed ID: 24469045
[TBL] [Abstract][Full Text] [Related]
39. Competition between PRC2.1 and 2.2 subcomplexes regulates PRC2 chromatin occupancy in human stem cells.
Youmans DT; Gooding AR; Dowell RD; Cech TR
Mol Cell; 2021 Feb; 81(3):488-501.e9. PubMed ID: 33338397
[TBL] [Abstract][Full Text] [Related]
40. Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.
Natsume A; Ito M; Katsushima K; Ohka F; Hatanaka A; Shinjo K; Sato S; Takahashi S; Ishikawa Y; Takeuchi I; Shimogawa H; Uesugi M; Okano H; Kim SU; Wakabayashi T; Issa JP; Sekido Y; Kondo Y
Cancer Res; 2013 Jul; 73(14):4559-70. PubMed ID: 23720055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
